
What We’re Reading: Medicaid Health Plans Protect Members; Bayer to Expand R&D in US; Most Fatal Poisonings in Young Children Due to Opioids
Medicaid plans begin planning for the upcoming lapse in continuous coverage starting April 1, 2023; Bayer plans to spend $1 billion on US pharmaceutical research and development in 2023; opioids were the most common cause of death by poisoning in young children.
Medicaid Health Plans Will Attempt to Protect Members, Profits, After Lapse
Since 2020, when COVID-19 pandemic protections allowed Medicaid enrollees to automatically keep their coverage without needing to reapply. However, beginning April 1, 2023, states can begin disenrolling Medicaid enrollees who no longer qualify and large health care insurers hope to keep enrollees who are still eligible and move those who lose coverage onto Affordable Care Act marketplace plans,
Bayer Intends to Spend $1B on US Pharma R&D in 2023
Drugmaker Bayer AG plans to spend $1 billion on drug research and development in the United States in 2023 as it attempts to double its nationwide sales by the end of 2030, said Sebastian Guth, Bayer’s top US pharmaceutical executive,
Opioids Most Common Cause of Fatal Poisoning in Young Children, Study Finds
A study found that opioids were the most common cause of fatal poisoning in children ages 5 and younger, with most of the deaths in infants, between 2005 and 2018,
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.